Key Market Insights
At present, more than 100 long-acting drug delivery technologies are being offered by companies across the globe in order to develop long-acting drugs for a myriad of disease indications
Nearly 90% of the technologies are based on manipulation of drug release profile; majority of these technologies can support the development of long-acting injectables with dosing interval of at least a month
In pursuit of gaining a competitive edge, industry stakeholders are actively innovating and developing novel long-acting drug delivery technologies that can be utilized across multiple therapeutic areas
The current service providers landscape features the presence of over 40 companies, offering a wide range of development and manufacturing services for the long-acting delivery of drugs
The market is fragmented, featuring the presence of both established players and small firms that have the expertise to develop / manufacture long-acting drugs / delivery systems for various dosage forms
In order to cater to the evolving needs of clients, several service providers claim to be steadily expanding their existing capabilities to enhance their respective service portfolio
The growing interest in this domain is clearly evident from the rise in partnership activity; in fact, more than 60 collaborations related to long-acting drug delivery were inked in the last three years
~575 scientific articles published recently signify the focused efforts being led by researchers to identify and develop novel long-acting technologies and therapeutic interventions
Over 1,200 patents related to long-acting drug delivery have been filed / granted by various stakeholders in order to protect the intellectual property generated within this field
400+ grants have been awarded for the ongoing RD efforts for long acting drug delivery; University of North Carolina and John Hopkins University have emerged as the most popular recipient organizations
The market opportunity associated with long-acting drug delivery technologies is anticipated to witness an annualized growth of nearly 13% over the next decade
The market opportunity is expected to be well distributed across different compatible dosage forms, types of molecules supported and key geographical regions
1. PREFACE
1.1. Introduction
1.2. Key Market Insights
1.3. Scope of the Report
1.4. Research Methodology
1.5. Frequently Asked Questions
1.6. Chapter Outlines
2. EXECUTIVE SUMMARY
3. INTRODUCTION
3.1. Chapter Overview
3.2. Overview of Long-Acting Drug Delivery
3.3. Long-Acting Drug Delivery Technologies
3.4. Concluding Remarks
4. TECHNOLOGY LANDSCAPE
4.1. Chapter Overview
4.2. Long-Acting Drug Delivery: Technology Landscape
4.3. Long-Acting Drug Delivery: Technology Developers Landscape
5. SERVICE PROVIDERS LANDSCAPE
5.1. Chapter Overview
5.2. Long-Acting Drug Delivery: Service Providers Landscape
6. TECHNOLOGY COMPETITIVENESS ANALYSIS
6.1. Chapter Overview
6.2. Assumptions / Key Parameters
6.3. Methodology
6.4. Technology Competitiveness Analysis
7. COMPANY COMPETITIVENESS ANALYSIS
7.1. Chapter Overview
7.2. Assumptions / Key Parameters
7.3. Methodology
7.4. Company Competitiveness Analysis
8. COMPANY PROFILES
8.1. Chapter Overview
8.2. Adare Pharma Solutions
8.2.1. Company Overview
8.2.2. Technology Portfolio
8.2.3. Service Portfolio
8.2.4. Recent Developments and Future Outlook
8.3. AMW
8.4. Bostal Drug Delivery
8.5. Creative Biolabs
8.6. ForDoz Pharma
8.7. InnoCore Pharmaceuticals
8.8. Integral BioSystems
8.9. LATITUDE Pharmaceuticals
8.10. Navin Saxena Research and Technology Centre (NSRT)
8.11. Samyang Biopharm
9. PARTNERSHIPS AND COLLABORATIONS
9.1. Chapter Overview
9.2. Partnership Models
9.3. Long-Acting Drug Delivery Technologies and Services: Partnerships and Collaborations
10. PUBLICATION ANALYSIS
10.1. Chapter Overview
10.2. Scope and Methodology
10.3. Long-Acting Drug Delivery: Publication Analysis
11. PATENT ANALYSIS
11.1. Chapter Overview
11.2. Scope and Methodology
11.3. Long-Acting Drug Delivery: Patent Analysis
11.4. Patent Benchmark Analysis
11.5. Patent Valuation Analysis
12. GRANT ANALYSIS
12.1. Chapter Overview
12.2. Scope and Methodology
12.3. Long-Acting Drug Delivery: Grant Analysis
13. MARKET FORECAST AND OPPORTUNITY ANALYSIS
13.1. Chapter Overview
13.2. Key Assumptions and Forecast Methodology
13.3. Global Long-Acting Drug Delivery Technologies Market, 2023-2035
13.4. Global Long-Acting Drug Delivery Services Market, 2023-2035
14. CONCLUSION
15. INTERVIEW TRANSCRIPTS
16. APPENDIX 1: TABULATED DATA
17. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS
To view more details on this report, click on the link
https://www.rootsanalysis.com/reports/long-acting-drug-delivery-market.html
You may also be interested in the following titles:
Nanoparticle Formulation Market |
About Roots Analysis
Roots Analysisis a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.
Contact:
Ben Johnson
+1 (415) 800 3415
